High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy

Kidney International

Volumn 66, Issue 3, 2004, Pages 1107-1114

  Toyoda, Masao ^a   Suzuki, Daisuke ^a   Honma, Masashi ^a   Uehara, Goro ^a   Sakai, Takako ^a   Umezono, Tomoya ^a   Sakai, Hideto ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic nephropathy; In situ hybridization; Mitogen activated protein kinase; Protein kinase C; Transforming growth factor

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; PROTEIN KINASE C BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 4344609666     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00798.x     Document Type: Article

References (50)

1. CRAVEN PA, DAVIDSON CM, DERUBERTIS FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674, 1990
2. WILLIAMS B, SCHRIER RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896, 1993
3. CRAVEN PA, DERUBERTIS FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats: Possible mediation by glucose. J Clin Invest 83:1667-1675, 1989
4. KIKKAWA R, HANEDA M, UZU T, et al: Translocation of protein kinase C α and ξ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37:838-841, 1994
5. TOYODA M, SUZUKI D, ZHANG SY, et al: In-situ hybridization studies of protein kinase C α and β I isoforms in human diabetic nephropathy. Clin Exp Nephrol 5:250-256, 2001
6. HANEDA M, ARAKI S, TOGAWA M, et al: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
7. KOYA D, KING GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
8. XIAO ZL, ANDRADA MJ, BIANCANI P, et al: Reactive oxygen species (H(2)O(2)): Effects on the gallbladder muscle of guinea pigs. Am J Physiol Gastrointest Liver Physiol 282:G300-G306, 2002
9. ALETSEE C, BRORS D, PALACIOS S, et al: The effects of laminin-1 on spiral ganglion neurons are dependent on the MEK/ERK signaling pathway and are partially independent of Ras. Hear Res 164:1-11, 2002
10. UEDA Y, HIRAI S, OSADA S, et al: Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519, 1996
11. GRAVES JD, CAMPBELL JS, Krebs EG: Protein serine/threonine kinases of the MAPK cascade. Ann N Y Acad Sci 766:320-343, 1995
12. SEGER R, KREBS EG: The MAPK signaling cascade. FASEB J 9:726-735, 1995
13. SUN QY, BREITBART H, SCHATTEN H: Role of the MAPK cascade in mammalian germ cells. Reprod Fertil Dev 11:443-450, 1999
14. MARSHALL CL: Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-85, 1995
15. SEGER R, KREBS EG: The MAPK signaling cascade. FASEB J 9:726-735, 1995
16. KARIN M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486, 1995
17. PAYNE DM, ROSSOMANDO AJ, MARTINO P, et al: Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10:885-892, 1991
18. GELLMAN DD, PIRANI CL, SOOTHILL JF, et al: Diabetic nephropathy: A clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 38:312-367, 1959
19. NOMOTO Y, TOMINO Y, ENDOH M, et al: Modified open renal biopsy: Results in 934 patients. Nephron 45:224-228, 1987
20. SUZUKI D, MIYAZAKI M, NAKA R, et al: In situ hybridization of interleukin 6 in diabetic nephropathy. Diabetes 44:1233-1238, 1995
21. SUZUKI D, MIYAZAKI M, JINDE K, et al: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52:111-119, 1997
22. NISHIZUKA Y: The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308:693-698, 1984
23. NISHIZUKA Y: Studies and perspective of protein kinase C. Science 233:305-312, 1986
24. LYNCH JJ, FERRO TJ, BLUMENSTOCK FA, et al: Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991-1998, 1990
25. RASMUSSEN H, FORDER J, KOJIMA I, et al: TPA-induced contraction of isolated rabbit vascular smooth muscle. Biochem Biophys Res Commun 122:776-784, 1984
26. KARIYA K, KAWAHARA Y, TSUDA T, et al: Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis 63:251-255, 1987
27. HUHTALA P, CHOW LT, Tryggvason K: Structure of the human type IV collagen gene. J Biol Chem 265:11077-11082, 1990
28. HACHIYA HL, TAKAYAMA S, WHITE MF, et al: Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol esters. J Biol Chem 262:6417-6424, 1987
29. PRESTA M, MAIER JAM, RAGNOTTI G: The mitogenic signaling pathway but not plasminogen activator inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Cell Biol 109:1877-1884, 1989
30. ISHII H, KOYA D, KING GL: Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 76:21-31, 1998
31. NISHIZUKA Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 255:607-614, 1992
32. KOYA D, JIROUSEK MR, LIN Y-W, et al: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
33. YAMAGUCHI K, OGITA K, NAKAMURA S, et al: The protein kinase C isoforms leading to MAP-kinase activation in CHO cells. Biochem Biophys Res Commun 210:639-647, 1995
34. TOMLINSON DR: Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42:1271-1281, 1999
35. INOKI K, HANEDA M, ISHIDA T, et al: Role of mitogen-activated protein kinases as downstream effectors of transforming growth factor-β in mesangial cells. Kidney Int 58(Suppl 77):S76-S80, 2000
36. ISHII H, JIROUSEK MR, KOYA D, et al: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
37. KOYA D, HANEDA M, NAKAGAWA H, et al: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-147, 2000
38. HOSHI S, NOMOTO K, KUROMITSU J, et al: High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290:177-184, 2002
39. ISONO M, CRUZ MC, CHEN S, et al: Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11:2222-2230, 2000
40. LIU W, SCHOENKERMAN A, Lowe WL JR.: Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 279:E782-E790, 2000
41. NISHIDA E, GOTOH Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18:128-131, 1993
42. SHARMA K, ZIYADEH FN, ALZAHABI B, et al: Increased renal production of transforming growth factor-β 1 in patients with type II diabetes. Diabetes 46:854-859, 1997
43. SAKAI H, NAKA R, SUZUKI D, et al: In situ hybridization analysis of TGF-β in glomeruli from patients with IgA nephropathy. Contrib Nephrol 111:107-114, 1995
44. COHEN MP, SHARMA K, JIN Y, et al: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists: A novel treatment strategy. J Clin Invest 95:2338-2345, 1995
45. MOGYOROSI A, ZIYADEH FN: Update on pathogenesis, markers, and management of diabetic nephropathy. Curr Opin Nephrol Hypertens 5:243-253, 1996
46. ZIYADEH FN: Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab 21:292-302, 1995
47. WOLF G, ZIYADEH FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 65:393-405, 1999
48. SHARMA K, ZIYADEH FN: Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17:80-92, 1997
49. DU X-L, EDELSTEIN D, ROSSETTI L, et al: Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222-12226, 2000
50. ZIYADEH FN, MOGYOROSI A, KALLURI R: Editorial review: Early and advanced nonenzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol 5:2-9, 1997